Harrow Health

$5.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.67%) Today

$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell Harrow Health and other stocks, options, and ETFs commission-free!

About HROW

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN. The listed name for HROW is Harrow Health, Inc. Common Stock.

CEO

Mark L. Baum

Employees

133

Headquarters

Nashville, Tennessee

Founded

2006

Market Cap

153.45M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

193.76K

High Today

$6.20

Low Today

$5.86

Open Price

$6.09

Volume

120.95K

52 Week High

$7.92

52 Week Low

$3.33

Collections

HROW Earnings

-$0.50

-$0.19

$0.12

$0.43

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 8, After Hours